Page 43 - Read Online

Sobenin et al. Desialylated LDL in diabetes

Dr. Tiina Solakivi (University of Tampere, Tampere, aortic cells. Atherosclerosis 1993;100:41-54.
Finland) in methodologic supervising of preliminary 14. Sobenin IA, Tertov VV, Orekhov AN. Characterization of chemical
studies with LDL density fractionation. composition of native and modified low density lipoprotein occurring
in the blood of diabetic patients. Int Angiol 1994;13:78-83.
Financial support and sponsorship 15. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC,
Krauss RM. Low-density lipoprotein subclass patterns and risk of
This study was supported in part by Russian Ministry of myocardial infarction. JAMA 1988;260:1917-21.
Education and Science, Project #RFMEFI61614X0010. 16. Musliner TA, Krauss RM. Lipoprotein subspecies and risk of coronary
disease. Clin Chem 1988;34:B78-83.
Conflicts of interest 17. Packard CJ. Small dense low-density lipoprotein and its role as an
There are no conflicts of interest. independent predictor of cardiovascular disease. Curr Opin Lipidol
2006;17:412-7.
18. Ivanova EA, Bobryshev YV, Orekhov AN. LDL electronegativity
Patient consent index: a potential novel index for predicting cardiovascular disease.
All involved patients gave their consent forms. Vasc Health Risk Manag 2015;11:525-32.
19. Puavilai G, Chanprasertyotin S, Sriphrapradaeng A. Diagnostic criteria
Ethics approval for diabetes mellitus and other categories of glucose intolerance: 1997
criteria by the Expert Committee on the Diagnosis and Classification
This study was approved by the local ethics committee of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and
of the Institute for Atherosclerosis Research, Skolkovo 1985 WHO criteria. World Health Organization. Diabetes Res Clin
Innovation Center, Moscow, Russia. Pract 1999;44:21-6.
20. Lindgren FT. Preparative ultracentrifugal laboratory procedures and
REFERENCES suggestions for lipoproten analysis. In: Perkins EG, editor. Analysis
of lipids and lipoproteins. New York: American Oil Chemical Society;
1. Ghosh P, Sahoo R, Vaidya A, Chorev M, Halperin JA. Role of 1975. p. 205-24.
complement and complement regulatory proteins in the complications 21. Tertov VV, Sobenin IA, Tonevitsky AG, Orekhov AN, Smirnov
of diabetes. Endocr Rev 2015;36:272-88. VN. Isolation of atherogenic modified (desialylated) low density
2. Nathan DM, Bayless M, Cleary P, Genuth S, Gubitosi-Klug R, Lachin lipoprotein from blood of atherosclerotic patients: separation from
JM, Lorenzi G, Zinman B; DCCT/EDIC Research Group. Diabetes native lipoprotein by affinity chromatography. Biochem Biophys Res
control and complications trial/epidemiology of diabetes interventions Commun 1990;167:1122-7.
and complications study at 30 years: advances and contributions. 22. Jaakkola O, Solakivi T, Ylä-Herttuala S, Nikkari T. Receptor-
Diabetes 2013;62:3976-86. mediated binding and degradation of subfractions of human plasma
3. Moore DJ, Gregory JM, Kumah-Crystal YA, Simmons JH. Mitigating low-density lipoprotein by cultured fibroblasts. Biochim Biophys Acta
micro-and macro-vascular complications of diabetes beginning in 1989;1005:118-22.
adolescence. Vasc Health Risk Manag 2009;5:1015-31. 23. Jaakkola O, Solakivi T, Tertov VV, Orekhov AN, Miettinen TA,
4. Aronson D, Edelman ER. Coronary artery disease and diabetes Nikkari T. Characteristics of low-density lipoprotein subfractions
mellitus. Heart Fail Clin 2016;12:117-33. from patients with coronary artery disease. Coron Artery Dis
5. Kones R. Primary prevention of coronary heart disease: integration 1993;4:379-85.
of new data, evolving views, revised goals, and role of rosuvastatin 24. Hara A, Radin NS. Lipid extraction of tissues with a low-toxicity
in management. A comprehensive survey. Drug Des Devel Ther solvent. Anal Biochem 1978;90:420-6.
2011;5:325-80. 25. Siedel J, Hägele EO, Ziegenhorn J, Wahlefeld AW. Reagent for
6. Goldstein JL, Brown MS. A century of cholesterol and coronaries: enzymatic determination of serum total cholesterol with improved
from plaques to genes to statins. Cell 2015;161:161-72. lipolytic efficiency. Clin Chem 1983;29:1075-80.
7. Shi H, Mao X, Zhong Y, Liu Y, Zhao X, Yu K, Zhu R, Wei Y, Zhu J, 26. Lowry OH, Rosebrough NJ, Farr AL, Randall BJ. Protein measurement
Sun H, Mao Y, Zeng Q. Lanatoside C promotes foam cell formation with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
and atherosclerosis. Sci Rep 2016;6:20154. 27. Lipid Research Clinics Program. In: Manual of Laboratory Operations,
8. Das A, Brown MS, Anderson DD, Goldstein JL, Radhakrishnan A. Lipid and Lipoprotein Analysis, DHEW Publication No. (NIH) 75-
Three pools of plasma membrane cholesterol and their relation to 628. 2nd ed. Washington, DC: U. S. Government Printing Office;
cholesterol homeostasis. Elife 2014;3:02882. 1974. p. 1-81.
9. Yang H, Mohamed AS, Zhou SH. Oxidized low density lipoprotein, 28. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma
stem cells, and atherosclerosis. Lipids Health Dis 2012;11:85. low density lipoproteins in normal humans. J Lipid Res 1982;23:97-
10. Orekhov AN, Melnichenko AA, Sobenin IA. Approach to reduction 104.
of blood atherogenicity. Oxid Med Cell Longev 2014;2014:738679. 29. Sobenin IA, Tertov VV, Orekhov AN. Optimization of the assay
11. Bobryshev YV, Ivanova EA, Chistiakov DA, Nikiforov NG, Orekhov for sialic acid determination in low density lipoprotein. J Lipid Res
AN. Macrophages and their role in atherosclerosis: pathophysiology 1998;39:2293-9.
and transcriptome analysis. Biomed Res Int 2016;2016:9582430. 30. Tsai NW, Lee LH, Huang CR, Chang WN, Chang YT, Su YJ, Chiang
12. Zakiev ER, Sukhorukov VN, Melnichenko AA, Sobenin IA, Ivanova YF, Wang HC, Cheng BC, Lin WC, Kung CT, Su CM, Lin YJ, Lu
EA, Orekhov AN. Lipid composition of circulating multiple-modified CH. Statin therapy reduces oxidized low density lipoprotein level, a
low density lipoprotein. Lipids Health Dis 2016;15:134. risk factor for stroke outcome. Crit Care 2014;18:R16.
13. Sobenin, IA, Tertov VV, Koschinsky T, Bünting CE, Slavina ES, 31. Liu Y, Atkinson D. Enhancing the contrast of ApoB to locate the
Dedov II, Orekhov AN. Modified low density lipoprotein from surface components in the 3D density map of human LDL. J Mol Biol
diabetic patients causes cholesterol accumulation in human intimal 2011;405:274-83.
36 Vessel Plus ¦ Volume 1 ¦ March 31, 2017